29
Sep
2020
17:30
BST
Webinar
Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based Discussion
-
Views:
700
-
Likes:
2
Overview
LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF. In the era of NOACs the clinical evidence is also emerging. Join the panelists to discuss the implications of current and future trials on clinical practice. A live case from the University Clinic Aarhus, Denmark will focus on intracardiac echocardiography (ICE) to guide the LAA closure procedure with the next generation device WATCHMAN FLX.
Faculty:
Ignacio Cruz
Jens Erik Nielsen Kudsk
Prof Henning Ebelt
Marek Grygier
Tim Betts
Caroline Kleinecke
This webinar is supported by
Learning Objectives
- Discuss the emerging evidence for the LAA closure therapy in the era of NOACs
- Follow a live case with WATCHMAN FLX guided by ICE imaging
- Learn how new workstreams with ICE can reduce the need for General Anaesthesia
- Understand the benefits of combined procedures (AF Ablation + LAA closure) for patients
- Learn about the trial design and endpoints of the OPTION trial and discuss the implication on clinical practice.
- Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results
Audience
- Interventional Cardiologists and Electrophysiologists who would like to learn more about the growing evidence for the LAA closure therapy with WATCHMAN FLX
- Non-invasive Cardiologists with an interest in the clinical evidence and the implications for the LAA closure therapy
Faculty Biographies
Ignacio Cruz
Prof Cruz is a Professor of Medicine at the University of Salamanca, Chief of Interventional Cardiology and Elected President of the Spanish Society of Interventional Cardiology.
Jens Erik Nielsen Kudsk
Jens Erik Nielsen Kudsk is a Professor of Cardiology and Head of Structural Heart Interventions at Aarhus University Hospital, Denmark.
Tim Betts
John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK
Key References
1. OPTION
https://www.bostonscientific.com/en-US/products/laac-system/option-clinical-trial.html
https://clinicaltrials.gov/ct2/show/NCT03795298
2. ICE-LAA
https://clinicaltrials.gov/ct2/show/NCT04196335
3. ASAP TOO
https://www.bostonscientific.com/en-US/products/laac-system/asap-too.html
https://clinicaltrials.gov/ct2/show/NCT02928497